Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
DNAtrix logo — company profile

DNAtrix

Founded 2005 United States San Diego, United States 3 employees Series Unknown Total: $57.08M Biotechnology, Health Care

General Information

Company Name DNAtrix
Founded Year 2005
Location United States San Diego, United States +1
Employees 3
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when DNAtrix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DNAtrix

DNAtrix is a biotech company pioneering virus-driven immunotherapies for cancer treatment. This United States-based startup's proprietary adenovirus platform utilizes an engineered version of the common cold virus to selectively infect and destroy cancer cells while sparing healthy cells. Their lead product, DNX-2401, is poised to begin a global pivotal Phase 3 clinical study for patients with recurrent glioblastoma. FDA Fast Track and Rare Pediatric Disease designations have also been granted for its evaluation in a Phase 1 study for diffuse intrinsic pontine glioma. Additionally, DNX-2440, their second product candidate, is entering a Phase 1 clinical study for colorectal and other cancers with liver metastasis. Notably, the company has secured a $15.53M Venture Round investment from key investors Morningside Ventures and Mercury Fund in September 12, 2018.

Taxonomy: Biotech, Immunotherapy, Cancer Treatment, Oncolytic Virus, Glioblastoma, Clinical Research, Virology, Molecular Biology, Drug Development, Adenovirus, Rare Pediatric Disease, Phase 3 Clinical Study, Brain Tumor, Metastasis, Investment

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 12 Sep 2018
Convertible Note •••••• 1
Investor
01 Dec 2016
Grant •••••• 1 •••• •••• 04 Aug 2016
Series B •••••• 4
Investor Investor
•••• •••• 		14 Oct 2014
Grant •••••• 1 •••• •••• 24 Feb 2014

View All 13 Funding Rounds

DNAtrix Alternatives & Competitors

DNAtrix vs
Genelux
Genelux United States

Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology company focused on improvi...

Post Ipo Equity
34 employees
Biopharma, Biotechnology
DNAtrix vs
Gradalis, Inc.
Gradalis, Inc. United States

Leading a new way to fight cancer

Grant
24 employees
Biotechnology, Health Care
DNAtrix vs
Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. United States

A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer...

Post Ipo Secondary
13 employees
Biopharma, Biotechnology

FAQ About DNAtrix

DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer. Its proprietary adenovirus platform is based on an engineered version of the common cold virus that is designed to selectively infect and kill cancer cells while leaving healthy cells unharmed. The c...
DNAtrix was founded in 2005.
DNAtrix is headquartered in San Diego, United States.
DNAtrix operates in the following industries: Biotechnology, Health Care.
DNAtrix has approximately 3 employees.
DNAtrix has completed 13 funding rounds, raising a total of $57.08M. The latest funding stage is Series Unknown.
Top alternatives and competitors to DNAtrix include Genelux, Gradalis, Inc., Intensity Therapeutics, Inc., Genprex, Inc., Northwest Biotherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DNAtrix and Genelux are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DNAtrix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy